Zimmer Biomet Reports Second Quarter 2016 Financial Results

Go back to Zimmer Biomet Reports Second Quarter 2016 Financial Results

Jefferies Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q

July 29, 2016 7:51 AM EDT

Jefferies reiterated a Buy rating on Zimmer Biomet Holdings (NYSE: ZBH), and raised the price target to $150.00 (from $135.00), following the company's 2Q earnings report. GM was down 60bp, though OM was up 160bp as spending in SG&A was down 220bp. ZBH reported an... More

Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 5c; Boosts FY16 Outlook

July 28, 2016 7:39 AM EDT

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.02, $0.05 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.9 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2016 EPS of $7.90-$8.00, versus prior... More